Device manufacturer Gerresheimer reported a 6.3% increase in revenues and a 7.4% increase in net income in the second quarter of 2015, crediting “very strong growth” in medical plastic products such as inhalers. According to the company, it is continuing to expand its production capacity for inhalers and other plastic products in the Czech Republic and in the US.
Gerresheimer said that it expects 1-3% organic revenue growth for the 2015 financial year and annual organic revenue growth of 4-6% from 2016-2018. CEO Uwe Röhrhoff commented, “We continue to deliver our growth strategy. We will continue to achieve profitable growth as we are well positioned worldwide and reap the benefits of long-term megatrends in healthcare.”
Read the Gerresheimer press release.
